Published in J Neural Transm (Vienna) on September 10, 2008
Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol (2009) 1.46
D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci (2012) 0.93
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
The structure of haplotype blocks in the human genome. Science (2002) 50.88
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics (2005) 5.14
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry (2002) 3.78
5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry (1976) 3.15
Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry (2001) 2.00
Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci (2002) 1.24
Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain (2007) 1.19
A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res (2000) 1.19
A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry (2001) 1.19
Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.10
Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res (2001) 1.09
Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Dev Biol (1995) 1.04
Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav (2007) 1.01
CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry (1990) 1.00
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. J Psychiatr Res (1986) 0.99
Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord (2001) 0.98
Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.97
Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand (1985) 0.94
Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry (2004) 0.93
Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry (1996) 0.92
Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology (Berl) (1976) 0.90
CSF monoamine metabolites in melancholia. Acta Psychiatr Scand (1984) 0.90
5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol (1985) 0.89
Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp Neurol (1999) 0.89
Development of pontine noradrenergic A5 neurons requires brain-derived neurotrophic factor. Eur J Neurosci (2005) 0.88
Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci (1994) 0.87
Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur J Neurosci (1995) 0.83
CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Psychiatry Res (2003) 0.83
The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res (1994) 0.81
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro. Brain Res Dev Brain Res (1994) 0.81
Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp Neurol (1995) 0.80
Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Arch Gen Psychiatry (1980) 0.77
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex (2009) 2.88
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Model of the long-term transport and accumulation of radionuclides in future landscapes. Ambio (2013) 2.08
Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol Aging (2009) 2.08
Up-regulation of NOTCH4 gene expression in bipolar disorder. Am J Psychiatry (2012) 2.04
Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res (2010) 1.98
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One (2007) 1.85
A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. Proc Natl Acad Sci U S A (2009) 1.84
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp (2004) 1.76
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord (2009) 1.74
Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry (2010) 1.73
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J Clin Invest (2007) 1.63
Sex-dependent association of common variants of microcephaly genes with brain structure. Proc Natl Acad Sci U S A (2009) 1.55
Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet (2008) 1.50
Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: a multi-sample MRI study. Neuroimage (2009) 1.42
Schizophrenia--what does structural MRI show? Tidsskr Nor Laegeforen (2013) 1.41
A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord (2010) 1.40
Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res (2007) 1.39
Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A (2006) 1.38
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry (2011) 1.36
Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry (2012) 1.32
Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect Immun (2003) 1.32
An evolutionarily conserved sexual signature in the primate brain. PLoS Genet (2008) 1.21
Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. J Psychiatry Neurosci (2010) 1.19
Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system. PLoS One (2007) 1.19
NK cells: elusive players in autoimmunity. Trends Immunol (2005) 1.17
Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet (2006) 1.12
Assessment of long-term radiological effects on plants and animals from a deep geological repository: no discernible impact detected. Ambio (2013) 1.12
DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol (2006) 1.11
[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem Int (2008) 1.11
PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse (2004) 1.11
Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.10
Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci (2003) 1.08
PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry (2002) 1.07
Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am J Psychiatry (2002) 1.05
Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nat Med (2011) 1.03
Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int Immunol (2004) 1.02
c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur J Immunol (2010) 1.01
Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease. J Neurosci (2009) 1.01
Genome-wide prediction of human VNTRs. Genomics (2005) 1.01
Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp (2003) 1.00
Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr Res (2008) 1.00
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res (2011) 1.00
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol (2005) 0.99
Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology (2006) 0.99
Quantitative study of synthetic Hox transcription factor-DNA interactions in live cells. Proc Natl Acad Sci U S A (2010) 0.99
Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem (2002) 0.99
Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage (2003) 0.98
Inferences about radionuclide mobility in soils based on the solid/liquid partition coefficients and soil properties. Ambio (2013) 0.97
Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nucl Med Biol (2003) 0.97
Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology (2005) 0.96
BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2006) 0.96
Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nucl Med Biol (2012) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry (2008) 0.95
Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse (2005) 0.95
Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls. Br J Psychiatry (2014) 0.95
Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res (2004) 0.94
YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun (2004) 0.94
Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl Med Biol (2005) 0.94
Selection for tameness has changed brain gene expression in silver foxes. Curr Biol (2005) 0.94
D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci (2012) 0.93
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol (2015) 0.93
Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults. Psychiatry Res (2010) 0.93
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. J Psychiatry Neurosci (2012) 0.93
Prodynorphin storage and processing in axon terminals and dendrites. FASEB J (2006) 0.93
Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J (2005) 0.92
CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One (2013) 0.92
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry (2010) 0.92
Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples. Am J Med Genet B Neuropsychiatr Genet (2011) 0.92
High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder. Compr Psychiatry (2012) 0.91
Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Brain Res (2002) 0.91
The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet (2008) 0.91
Apathy and functioning in first-episode psychosis. Psychiatr Serv (2009) 0.91
Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophr Res (2010) 0.91